BioAge Labs Appoints Jean-Pierre Garnier as Chair of Board of Directors
Key Highlights BioAge Labs appoints Jean-Pierre Garnier, PhD, as Chair of the Board of Directors. Garnier brings extensive leadership experience from…
Browsing Tag
Sofinnova Investments
7 posts
Sofinnova Investments Welcomes Dr. Maha Radhakrishnan as Executive Partner
Key Highlights Maha Radhakrishnan, M.D. joins Sofinnova Investments as Executive Partner. Over 20 years of industry experience in…
Marea Therapeutics Launches with $190 Million to Transform Cardiometabolic Disease Treatment
Key Highlights $190 million in Series A and B financings led by top investors. MAR001 targets ANGPTL4 to…
PureTech Health Advances Strategic Initiatives, Launches Seaport Therapeutics
Key Highlights Seaport Therapeutics launches with $100M in Series A financing to develop neuropsychiatric medicines. Leadership Transition: Daphne Zohar steps…
Avenzo Therapeutics Closes $150M Series A-1 Financing
Key Highlights Oversubscribed $150 million Series A-1 financing led by New Enterprise Associates, Deep Track Capital, Sofinnova Investments, and…
Capstan Therapeutics Secures $175M in Series B
Key Highlights $175M Series B financing led by RA Capital Management with broad investor participation. Funds to advance CPTX2309, Capstan’s…
BioAge Secures $170M for Obesity Drug Development
Key Highlights $170 million Series D financing led by Sofinnova Investments with participation from top investors and pharma companies.…